Update on fetal hemoglobin gene regulation in hemoglobinopathies
about
Genomic approaches to identifying targets for treating β hemoglobinopathiesFrom stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modificationsModulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approachesPregnancy in women with thalassemia: challenges and solutionsChemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2Extrinsic and intrinsic control by EKLF (KLF1) within a specialized erythroid niche.Molecular mechanism of yisui shengxue granule, a complex chinese medicine, on thalassemia patients suffering from hemolysis and anemia of erythrocytesTranscriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.Nuclease-mediated gene editing by homologous recombination of the human globin locus.Fetal hemoglobin in sickle cell anemiaA functional element necessary for fetal hemoglobin silencingFetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyurea.β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.The multifunctional role of EKLF/KLF1 during erythropoiesis.Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels.Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity.Induction of human fetal hemoglobin expression by adenosine-2',3'-dialdehyde.Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell diseaseA systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell diseaseO-Linked N-Acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Interact with Mi2β Protein at the Aγ-Globin Promoter.Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells.Functional footprinting of regulatory DNA.Involvement of miRNA in erythroid differentiation.Skeletal muscle α-actin diseases (actinopathies): pathology and mechanisms.EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.Emerging science of hydroxyurea therapy for pediatric sickle cell disease.The Influence of Polymorphisms in Disease Severity in β-Thalassemia.Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia: A first report from Central Africa.Evaluation of the Effect of miR-26b Up-Regulation on HbF Expression in Erythroleukemic K-562 Cell LineMolecular basis of β thalassemia and potential therapeutic targets.Novel "omics" approach for study of low-abundance, low-molecular-weight components of a complex biological tissue: regional differences between chorionic and basal plates of the human placenta.Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice.Inducing indel mutation in the SOX6 Gene by Zinc Finger Nuclease for gamma reactivation: An Approach towards Gene Therapy of Beta Thalassemia.G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment.A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.Polymorphism in the HMOX1 gene is associated with high levels of fetal hemoglobin in Brazilian patients with sickle cell anemia.Pharmacological and molecular approaches for the treatment of β-hemoglobin disorders.Genome Editing of Erythroid Cell Culture Model Systems.
P2860
Q26799214-E5C0D6D5-3EDB-4277-A947-A20A2FEB1351Q26860339-19CE2FC3-4DE9-483C-8740-D04C63F7D697Q27027657-71F1133B-72F2-411C-9192-13F69D3631F3Q28080216-413DDE33-2590-4AB9-B1FE-1DFA6290122CQ28551340-A9AA6931-9FB5-40C3-B2C4-DD41269832B2Q33666771-B3D6695F-153C-4D93-8F0C-B04E4B19B4C0Q34770424-B3653E17-4C12-489B-BCB2-F32BDAEFD993Q34924307-80CA9E59-F046-4264-9915-253D77C5F8BBQ35025959-5BE78EB9-F7EC-4B54-90A5-2148E739D08BQ35114500-A2FDDA9E-2375-46F2-8564-141AB2C7837CQ35217485-8966C943-CFDC-4F20-A18F-60D52C149B13Q35230853-34F62976-518B-4001-83DA-DEA0B78073E4Q35485724-25DEBF59-5D91-4151-9A7A-5887AE64E1D7Q35797596-57032EF6-19F9-4BB6-B9BC-FEEF3FE73B11Q35904956-2AD56C92-443D-4E48-B155-AABD991D2C33Q36232895-09E74005-A434-4733-B3F9-B85426FF9F2DQ36291269-4A80F71D-C239-4AF6-B2AA-553C7A9A1BF5Q36688921-B5D7FCC1-9FEB-4444-BBF5-046806400AB7Q36777717-24179327-BDE2-40A1-8CD3-D050A1AAE5F4Q36792555-D2B380F6-6856-4898-A38B-7DD002842B78Q37117294-BDBA867A-15A5-447F-9EBD-016744B5BCDFQ37333153-3A9BE90B-AA00-439B-9797-159F69181EC0Q37717887-72CD995C-5DFE-4A43-A57E-E5D611D0DB0AQ37738675-2E556606-297D-4CAE-99A5-3F19D858F7C7Q37983889-EA51E952-D990-4E02-AB1C-4D26668D625BQ38028847-B4CD25DF-EADD-4E4C-B111-0E83094C432FQ38054642-D599729A-DB60-4088-B9C7-13CC7298DD9AQ38164192-CF8BFABC-B7EF-4570-99A8-29BAAE9A5E3BQ38542897-110F74AF-44F1-4FF1-A8C3-8F7362AC774FQ39002825-654D9F3F-1F86-4CAA-9D59-B58BA30D2F5CQ39024279-85FBCA8E-44A7-47BE-BF53-A5C55580C385Q39399184-5B29B241-1FDD-404B-907D-D1C583F8F50AQ40561932-15F5EF5C-A1B3-4C4E-83A8-727FA07DAFEDQ41457201-1B9BDE56-A836-4C15-B26E-9603C9566BD6Q41931448-9CF0E613-5A93-4AD7-9580-7C26FBB5704DQ42351641-4539E50D-0C47-4F76-A69C-6835BCAEBDD3Q42711553-380DFFD0-CC14-485E-A502-BFC79B5AC7C8Q44485168-35E49155-FE5F-4AA7-850B-7E4149202D41Q45874809-BA7152B2-E74C-41F8-9A0C-6A045F4A7624Q47405317-83792E46-574E-47C9-A943-EA0138C1EF97
P2860
Update on fetal hemoglobin gene regulation in hemoglobinopathies
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@ast
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@en
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@nl
type
label
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@ast
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@en
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@nl
prefLabel
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@ast
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@en
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@nl
P2860
P1476
Update on fetal hemoglobin gene regulation in hemoglobinopathies
@en
P2093
Daniel E Bauer
Stuart H Orkin
P2860
P356
10.1097/MOP.0B013E3283420FD0
P577
2011-02-01T00:00:00Z